Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory

Zong-Jian Liu1, Yuan-Yuan Ran1, Shu-Yan Qie1

  • 1Department of Rehabilitation, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.

Abstract

Insights

Melatonin reduces brain damage after ischemic stroke by shifting microglia from a pro-inflammatory to an anti-inflammatory state. This effect is mediated through the STAT3 pathway, offering a potential therapeutic strategy for stroke recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglia and macrophages are key players in stroke-induced inflammation.
  • Modulating microglia polarization is a potential therapeutic strategy for ischemic stroke.
  • Melatonin's neuroprotective effects in stroke are known, but its impact on microglia polarization is unclear.

Purpose of the Study:

  • To investigate the effect of melatonin on microglia polarization after ischemic stroke.
  • To elucidate the underlying mechanisms of melatonin's action on microglia.
  • To assess melatonin's therapeutic potential in a mouse model of ischemic stroke.

Main Methods:

  • Cerebral ischemia induced by middle cerebral artery occlusion (MCAO) in mice.
  • Melatonin administered intraperitoneally post-ischemia.
  • In vitro studies using BV2 microglial cells and N2a neuronal cells under oxygen-glucose deprivation (OGD).
  • Analysis of microglia phenotype markers via real-time PCR and STAT3 pathway activation via Western blot.

Main Results:

  • Melatonin treatment reduced infarct volume and improved neurological function in MCAO mice.
  • Melatonin inhibited pro-inflammatory responses in microglia and reduced neurotoxicity to neurons.
  • Melatonin enhanced STAT3 phosphorylation in microglia, and STAT3 blockade diminished melatonin's effects.

Conclusions:

  • Melatonin ameliorates brain damage following ischemic stroke.
  • Melatonin shifts microglia from a pro-inflammatory to an anti-inflammatory phenotype.
  • This neuroprotective effect is mediated, at least in part, by the STAT3 signaling pathway.

Related Concept Videos